Figure 3 | Scientific Reports

Figure 3

From: Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb

Figure 3

Clinical parameters.

Changes in various clinical parameters over the course of the second experiment, Group A is the rechallenged group while group B is the naïve control group. (A) Daily clinical score for each individual animal; (B) temperature; (C) white blood cell count (WBC); (D) platelet count (PLT); (E) alkaline phosphatase levels (ALP); (F) alanine aminotransferase levels (ALT); (G) amylase levels (AMY); and (H) % change in weight.

Back to article page